WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1998050022) DIPHENYLACETIC ACID DERIVATIVES AND THEIR USE AS ANTIVIRAL AGENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/1998/050022 International Application No.: PCT/GB1998/001313
Publication Date: 12.11.1998 International Filing Date: 06.05.1998
Chapter 2 Demand Filed: 22.10.1998
IPC:
C07C 219/10 (2006.01)
Applicants: GARNETT, David, John[GB/GB]; GB (UsOnly)
LOVESGROVE RESEARCH LIMITED[GB/GB]; Unit 2 Dyfi Eco-Park Machynlleth Powys SY20 8AX, GB (AllExceptUS)
Inventors: GARNETT, David, John; GB
Agent: ROYSTONS; Tower Building Water Street Liverpool L3 1BA, GB
Priority Data:
9709073.207.05.1997GB
9720837.502.10.1997GB
9804337.503.03.1998GB
Title (EN) DIPHENYLACETIC ACID DERIVATIVES AND THEIR USE AS ANTIVIRAL AGENTS
(FR) DERIVES D'ACIDE DIPHENYLACETIQUE ET LEUR UTILISATION COMME AGENTS ANTIVIRAUX
Abstract: front page image
(EN) A new broad-spectrum anti-viral compound for the treatment of viral infections, such as human immune deficiency virus. The compound has general formula (I). Ar1 and Ar2 are each either a phenyl group or substituted aromatic group; R1 is a primary, secondary or tertiary alkyl or alkenyl group, a phenyl or hydrogen; R2 is an alkyl group, a primary, secondary or tertiary alkyl amino group or hydrogen; and X is C, O, N or S. Preferred compounds include diethylamino-ethyl-2,2-diphenylvalerate and aminoethyl-2,2-diphenylvalerate.
(FR) L'invention concerne un nouveau composé antiviral à large spectre destiné au traitement d'infections virales, tel que le virus de l'immunodéficience humaine. Le composé présente la formule générale (I) dans laquelle: Ar1 et Ar2 représentent chacun soit un groupe phényle, soit un groupe aromatique substitué; R1 représente un groupe alkyle ou alcényle primaire, secondaire ou tertiaire, un phényle ou un hydrogène; R2 représente un groupe alkyle, un groupe alkylamine primaire, secondaire ou tertiaire ou un hydrogène; et X représente C, O, N ou S. De préférence, les composés comprennent diéthylamino-éthyl-2,2-diphénylvalérate et aminoéthyl-2,2-diphénylvalérate.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, GM, GW, HU, ID, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)